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a b s t r a c t
Granzyme B (GrzB) is expressed by activated T cells and mediates cellular apoptosis. GrzB also acts as an
extracellular protease involved in tissue degradation. We hypothesized that GrzB production from
activated memory CD4 T cells may be associated with HIV pathogenesis. We found that stimulated
memory CD4 T cells (via costimulation, cytokines, and TLR ligands) concomitantly produced GrzB and
HIV. Both GrzB and HIV expression were mainly restricted to CCR5-expressing memory CD4þCD45ROþ
T cells, including Th1 and Th17 subsets. Activated memory CD4 T cells also mediated tissue damage, such
as disruption of intestinal epithelial monolayers. In non-human primates, CD4 T cells of rhesus macaques
(pathogenic SIV hosts) expressed higher GrzB compared to African green monkeys (non-pathogenic SIV
hosts). These results suggest that GrzB from CCR5þ memory CD4 T cells may have a role in cellular and
tissue pathologies during HIV infection.
& 2014 Elsevier Inc. All rights reserved.
Introduction
HIV infection is characterized by CD4 T cell dysfunction and
death, chronic immune activation, and tissue pathologies includ-
ing lymph node destruction, enteropathy, adipose wasting, and
autoimmune diseases. The mechanisms and mediators by which
HIV infection causes these problems are complex and unclear. HIV
replicates most productively in memory CD4 T cells that are
activated by stimulants such as CD3/TCR agonism, cytokines, or
TLR ligands. These stimulants activate signaling pathways in
infected CD4 T cells such as NFκB to induce HIV replication. In
addition to activating HIV production, however, these stimulants
also upregulate other mediators in CD4 T cells such as cytokines,
chemokines, and enzymes such as granzyme B (GrzB), that
mediate CD4 T cell function, and that might function in HIV
pathogenesis. Because HIV production by memory CD4 T cells
involves mechanisms that also regulate GrzB production, we
explored the idea that HIV and GrzB may have a unique relation-
ship in activated CD4 T cells that could inﬂuence HIV pathogenesis.
Granzymes are serine proteases that have intracellular and
extracellular functions. Humans encode ﬁve granzymes (A, B, H, K,
and M), with GrzB being the best characterized. Although better
known as an important effector molecule of CD8 CTL's and NK cells
for eliminating infected or damaged cells, GrzB is important for
CD4 T cell effector functions as well. Naïve CD4þCD45RAþ T cells
do not express GrzB; CTL function and GrzB expression are
acquired following CD4 T cell activation and differentiation into
memory and effector subsets (Appay et al., 2002; Brown, 2010;
Zaunders et al., 2004). Antigen-speciﬁc CD4 CTL's eliminate
infected cells via GrzB/perforin and GrzA during infection with
viruses such as HIV, CMV, HSV, RSV, and LCMV (Casazza et al.,
2006; Hildemann et al., 2013; Loebbermann et al., 2012; Soghoian
et al., 2012; Yanai et al., 2003). CD4 CTL's are also important for
anti-tumor immunity by killing cancer cells via GrzB/perforin
(Quezada et al., 2010). Other effector CD4 T cell subsets including
Th1, Th17, and Tregs also produce GrzB for death-inducing or
suppressive functions (Ashley and Baecher-Allan, 2009; Cao et al.,
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2007; Gondek et al., 2005; Grossman et al., 2004; Loebbermann
et al., 2012; Sharma et al., 2006). We previously showed that
despite the higher constitutive intracellular protein expression of
GrzB by resting memory CD8 T cells compared to resting memory
CD4 T cells (puriﬁed from human peripheral blood), activated
memory CD4 T cells secrete substantial amounts of GrzB at similar
or higher levels than memory CD8 T cells (Medina et al., 2012).
GrzB from memory CD4 T cells is also biologically active because it
cleaves a speciﬁc substrate, kills bystander T cell lines, and induces
some disruption of Caco-2 epithelial monolayer integrity.
A key difference between natural (non-pathogenic) vs. non-
natural (pathogenic) SIV host non-human primates (NHP) is that
non-natural SIV hosts manifest AIDS-like complications similar to
humans, such as enteropathy and chronic immune activation,
whereas natural SIV hosts remain mostly pathogenesis-free with-
out these effects. The reasons for these differences are unclear, but
we found by immunohistochemical analysis of lamina propria
from NHP intestinal biopsies that uninfected non-natural SIV
hosts (rhesus macaques and pigtail macaques) contain more
GrzB-expressing CD4 T cells than natural SIV hosts (African green
monkeys and sooty mangabeys) (Hutchison et al., 2011). This data
suggested that GrzB from intestinal CD4 T cells could have a
pathological role in pathogenic SIV hosts. HIV and GrzB are
upregulated in memory CD4 T cells by similar stimulants and
secretory mechanisms, but whether there is an interdependent
relationship between HIV and GrzB in host cells, and if concomi-
tant release of HIV and GrzB from CD4 T cells inﬂuence HIV
pathogenesis is unknown.
The purpose of this study was to examine production of GrzB
by memory CD4 T cells during HIV infection, as well as to
determine the impact for induction of pathology. Within the pool
of memory CD4þCD45ROþ T cells (puriﬁed from peripheral blood
of healthy donors), we found that GrzB and HIV are produced
mostly from CCR5þ memory CD4 T cells during in vitro HIV
infection and stimulation. This association of GrzB and HIV by
CCR5þ memory CD4 T cells may have important implications for
HIV pathogenesis in vivo since CCR5 is highly expressed by
memory CD4 T cells in lymphoid, mucosal, and intestinal compart-
ments where substantial levels of HIV replication as well as tissue
damage occur.
Results
Secretion of GrzB by memory CD4 T cells during HIV infection
GrzB expressed by memory CD4 T cells, Th1, Th17, and Tregs is
involved in target cell suppression and apoptosis, and also func-
tions as an extracellular protease (Boivin et al., 2009; Hiebert and
Granville, 2012; Hildemann et al., 2013; Soghoian et al., 2012).
GrzB and HIV are upregulated in CD4 T cells by stimulants that
activate the NFκB pathway such as CD3/CD28 stimulation, and
cytokines such as IL2, IL7, and IL15. To assess GrzB and HIV
production from memory CD4 T cells, we ﬁrst examined extra-
cellular GrzB and HIV p24 from unactivated or activated (via CD3/
CD28 costimulation) memory CD4þCD45ROþ T cells (puriﬁed
from peripheral blood) after in vitro infection with HIV strains
(R5-, X4-, and R54-tropic). Unactivated, uninfected and HIV-
infected memory CD4 T cells released little to no GrzB after 2–4
days culture (o300 pg/ml), but increased to 1000 pg/ml by
6 days culture (perhaps driven by IL2 during the 24 h infection
period) (Fig. 1A). Unactivated, HIV-infected memory CD4 T cells
also produced increasing amounts of p24 (from 100 pg/ml at
2 days to 70,000 pg/ml by 6 days post-infection) (Fig. 1B). There
were no signiﬁcant differences in GrzB production between unin-
fected and HIV-infected memory CD4 T cells.
As expected, GrzB and HIV production in activated (CD3/CD28
costimulation) memory CD4 T cells was substantially higher
compared to unactivated memory CD4 T cells (Fig. 1C and D).
GrzB release from activated, uninfected memory CD4 T cells was
near maximal by 2 days post-infection (7000 pg/ml), and
remained high at 4 (4000 pg/ml) and 6 days post-infection
(8000 pg/ml) (Fig. 1C). HIV-infected memory CD4 T cells also
released similar amounts of GrzB 2–6 days post-infection
(4000–9,000 pg/ml), and HIV production (Fig. 1D) was robust
2–6 days post-infection (10,000 pg/ml at 2 days to 500,
000 pg/ml by 6 days).
We also examined if cytokines that enhance T cell activation
and HIV replication such as IL2, IL7, IL15, IL6, IL8, and TNFα also
promote GrzB production (Fig. 1E and F) (Chun et al., 1998;
Unutmaz et al., 1999). Unactivated memory CD4 T cells were
infected in the presence of cytokines, washed, and cultured for
6 days with cytokines. IL2 and IL15 alone, and in combination with
proinﬂammatory cytokines IL6, IL8, and TNFα, induced GrzB and
HIV production (100–700 pg/ml GrzB and 3000–18,000 pg/ml
p24, n¼3–4), whereas proinﬂammatory cytokines alone did not
induce GrzB. IL7 in combination with proinﬂammatory cytokines
also induced GrzB and HIV production. Thus, memory CD4 T cells
secrete substantial amounts of both GrzB and HIV during acute
infection, and extracellular GrzB strongly correlates with extra-
cellular p24 (Fig. 1G, n¼301). These results show that both GrzB
and HIV production are functions of activated memory CD4 T cells
during HIV infection.
Preferential expression of GrzB in CCR5þ memory CD4 T cells,
and relationship to CD4 CTL phenotype
GrzB expression in CD4 T cells is associated with memory
phenotype markers including CD45RO and CCR5 (Appay et al.,
2002; Grossman et al., 2004; Zaunders et al., 2004). CCR5 expres-
sion is also associated with HIV disease progression, CD4 T cell
depletion, and tissue pathologies (Brenchley et al., 2004;
Mattapallil et al., 2005; Yang et al., 2012). To determine the
relationship between GrzB and HIV coreceptors, we examined
intracellular GrzB in conjunction with CCR5 and CXCR4 in unin-
fected memory CD4þCD45ROþ T cells. Resting memory CD4 T
cells expressed high levels of CXCR4 and lower of levels of CCR5
(80% total CXCR4 and 40% total CCR5), which were both
modestly reduced after 24 h activation (Fig. 2B). In unactivated
and activated memory CD4 T cells, GrzB was expressed most by
CCR5þ memory CD4 T cells (Fig. 2C). Unactivated CXCR4/
CCR5 and CXCR4þ/CCR5 cells did not express intracellular
GrzB (o1% which was similar to isotype staining). However, GrzB
expression was 10% by CXCR4/CCR5þ and CXCR4þ/CCR5þ
cells (po0.05 compared to CXCR4/CCR5 and CXCR4þ/CCR5
cells, n¼4). CD3/CD28 costimulation increased GrzB modestly in
CXCR4/CCR5 (9.373.6%) and CXCR4þ/CCCR5 (2.771.2%)
subsets, but robustly in CXCR4/CCR5þ (52.1712.5%), and
CXCR4þ/CCR5þ (31.978.5%) subsets. GrzB in activated CXCR4/
CCR5þ and CXCR4þ/CCR5þ cells was also signiﬁcantly higher
than activated CXCR4/CCR5 and CXCR4þ/CCR5 cells (po
0.05). Although the overall expression levels of GrzB were higher
by CCR5þ memory CD4 T cells, the relative induction levels of
GrzB by costimulation were higher in CXCR4/CCR5 and
CXCR4þ/CCR5 cells (9-fold) compared to CXCR4/CCR5þ
and CXCR4þ/CCR5þ cells (4-fold). These data show that within
the population of memory CD4þCD45ROþ T cells, CCR5þ cells
harbor the most GrzB, although CCR5 negative memory CD4 T
cells may produce GrzB as well after T cell activation.
GrzB-expressing CD4 T cells are classiﬁed as CD4 CTL's that are
terminally-differentiated memory CD4þCD45ROþ T cells with
increased CD57, and decreased CD27 and CD28 expression
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Fig. 1. Production of GrzB and HIV by memory CD4 T cells during HIV infection. (A and B) Production of GrzB and HIV by non-preactivated (IL2 only stimulation) uninfected
or HIV-infected (R5-, X4-, or R54-tropic) memory CD4 T cells 2–6 days post-infection (means7sem, n¼5). (C and D) GrzB and HIV production by preactivated (CD3/CD28
costimulation) memory CD4 T cells 2–6 days post-infection (means7sem, n¼5). (E and F) GrzB and HIV production by non-preactivated, HIV-infected memory CD4 T cells
stimulated with common γ-chain and proinﬂammatory cytokines 6 days post-infection (n¼3–4). (G) Pearson correlation of extracellular GrzB and p24 by memory CD4 T
cells (n¼301).
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(Appay et al., 2002; Brown, 2010; Casazza et al., 2006). To better
understand GrzB expression in CCR5þ memory CD4 T cells in the
context of CD4 CTL phenotypes, we examined expression of CD57,
CD27, and CD28 in CCR5 and CCR5þ memory CD4 T cells. GrzB
expression was o3% in CCR5 memory CD4 T cells, but signiﬁ-
cantly higher at 415% (po0.05, n¼3) in CCR5þ memory CD4 T
cells (Fig. 2D–F). CD57 expression by CCR5 memory CD4 T cells
was 5%, and higher at 15% (po0.05) by CCR5þ memory CD4 T
cells (Fig. 2D). CD27 expression by CCR5 memory CD4 T cells was
65%, and lower at 25% (po0.05) by CCR5þ memory CD4 T
cells (Fig. 2E). CD28 expression by CCR5 memory CD4 T cells was
92%, and lower at 68% (po0.05) by CCR5þ memory CD4 T
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cells (Fig. 2F). These expression patterns indicate that
CCR5þGrzBþ memory CD4 T cells are not strictly associated with
markers of CD4 CTL's since CCR5þ cells that express CD27, as well
as CD28, also produce GrzB.
GrzB production by CCR5þ differentiated naïve CD4, Th1,
and Th17 cells
We additionally examined GrzB production by activated naïve
CD4 T cells since GrzB expression is acquired during differentiation
into memory and effector CD4 T cells (Fig. 3A–D). As expected,
initially puriﬁed naive CD4þ/CD45RAþ/CD45RO/CD62Lþ T
cells did not express CCR5 (Fig. 3A). However, this phenotype
changed on a small fraction of cells during 6 days culture so that
CD62L expression decreased and constitutive CCR5 expression was
increased on CD62L cells (with or without IL2). Longer-term
experiments (10 days) of uninfected and HIV-infected activated
naïve CD4 T cell stimulated with IL2 alone or CD3/CD28 costimu-
lationþ IL2 (generally Th1-polarizing conditions) showed that
differentiated naïve CD4 T cells coexpressed CCR5 and GrzB, in
conjunction with release of GrzB and p24 (Fig. 3B–D). Interest-
ingly, extracellular GrzB of differentiated naïve CD4 T cells was
increased by HIV infection in 3 experiments when cultured in IL2
only, and increased by infection in 2 of the 3 experiments if
costimulated and cultured with IL2 (Fig. 3C shows a representative
GrzB ELISA).
Th1 and Th17 effector CD4 T cells are HIV hosts that also
express GrzB. Th1 and Th17 effector functions are also associated
with numerous tissue pathologies. We puriﬁed Th1 and Th17 cells
from peripheral blood, infected them in vitro, and examined
GrzB and HIV production after 6 days culture 7 IL2 stimulation
(Fig. 3E–J). Cells were stimulated with PMA/IOþGolgiPlug for the
ﬁnal 5 h to examine GrzB coexpression with IFNγ (Th1) or IL17A
(Th17) in CCR5þ cells by ﬂow cytometry. Th1 and Th17 cells
secreted GrzB and HIV with IL2 stimulation, with surprisingly high
amounts of constitutive GrzB released by unstimulated Th1 cells
(Fig. 3E). Unstimulated, uninfected Th1 cells released 2500 pg/
ml GrzB, whereas HIV-infected Th1 cells released 5000 pg/ml
(po0.01 compared to uninfected Th1 cells, n¼4). IL2-stimulated,
uninfected and HIV-infected Th1 cells released similar amounts of
GrzB (4000 pg/ml). Unstimulated, uninfected or HIV-infected
Th17 cells released no GrzB, whereas IL2-stimulated, uninfected
Th17 cells released 600 pg/ml, and HIV-infected Th17 cells
released 3000 pg/ml GrzB (Fig. 3E, po0.05 compared to unin-
fected Th17 cells, n¼4). Stimulated, uninfected Th1 cells also
released more GrzB than Th17 cells (po0.01). HIV production by
Th1 cells and Th17 cells was 50,000 pg/ml by 6 days post-
infection (Fig. 3F). Lastly, after 6 days culture of Th1 and Th17 cells
in IL2 medium, GrzB coexpression with IFNγ or IL17A in CCR5þ
and CCR6þ (for Th17) cells was examined by intracellular cytokine
assay (PMA/IOþGolgiPlug during the ﬁnal 5 h of culture). Expres-
sion of IFNγ and GrzB was higher in CCR5þ cells compared to
CCR5 Th1 cells (Fig. 3G and H, po0.05, n¼4), and expression of
IL17A and GrzB was higher in CCR5þ/CCR6þ cells compared
CCR5/CCR6 Th17 cells (Fig. 3I and J, po0.05, n¼3). Thus,
coordinate release of GrzB and HIV can occur from speciﬁc
memory and effector CD4 T cell subsets, as well as from differ-
entiating naïve CD4 T cells following activation.
GrzB and HIV production by CCR5þ memory CD4 T cells during HIV
replication, and limited capacity of memory CD4 T cells to express
GrzB and p24 protein simultaneously
We next examined the relationship between intracellular GrzB
and HIV p24 protein in memory CD4 T cells during HIV replication.
We infected memory CD4 T cells and examined GrzB in
conjunction with p24 in CXCR4/CCR5 populations after 6 days
culture in IL2 medium (Fig. 4A and B). Uninfected CXCR4/CCR5
and CXCR4þ/CCR5 cells expressed no GrzB (1%, similar to
isotype staining), whereas CXCR4/CCR5þ cells expressed 13%
and CXCR4þ/CCR5þ cells expressed 8% GrzB (po0.05 com-
pared to
CXCR4/CCR5 and CXCR4þ/CCR5 cells, n420) (Fig. 4B left).
GrzB expression by uninfected memory CD4 T cells was mostly
unaffected following infection with HIV. Regardless of the HIV
strain used (R5-, X4-, or R54-tropic), we observed similar GrzB/
p24 percentages between strains in CXCR4/CCR5 populations and
therefore pooled all the infection data for analysis (Fig. 4B right).
Intracellular p24 was found in all CXCR4/CCR5 populations, but
was greatest in CXCR4/CCR5þ and CXCR4þ/CCR5þ cells (10–
20%, po0.05 compared to CXCR4/CCR5 and CXCR4þ/CCR5
cells, n420). GrzB without p24 expression was 14% in CXCR4/
CCR5þ cells, and 7% in CXCR4þ/CCR5þ cells (similar to unin-
fected cells). p24 without GrzB expression was 12% in CXCR4/
CCR5þ cells, and 20% in CXCR4þ/CCR5þ cells. However, a
minor percentage of dual-expressing GrzBþ/p24þ cells was
observed in CXCR4/CCR5þ and CXCR4þ/CCR5þ cells (3%),
indicating that a small fraction of infected CCR5þ memory CD4 T
cells is capable of simultaneous GrzB and p24 production. Thus,
GrzB and HIV are produced mostly by CCR5þ memory CD4 T cells,
mainly independently.
To further assess an interdependent relationship between GrzB
and HIV in memory CD4 T cells, we examined GrzB and HIV
expression during treatment of cells with pharmacological protein
inhibitors speciﬁc for GrzB (IETD-FMK compound) or HIV (pro-
tease inhibitor saquinavir). GrzB and p24 percentages in CCR5þ
cells were then examined (Fig. 4C). In uninfected cells, IETD-FMK
or saquinavir did not affect GrzB expression compared to
untreated cells. However, in HIV-infected cells, these compounds
had suppressive effects on both GrzB and HIV production. In
untreated (UT) cells: GrzB without p24 expression was 10.57
0.9%; p24 without GrzB was 15.670.9%; and dual-expressing
GrzBþ/p24þ cells was 2.670.2% (n420). In IETD-FMK treated
cells: GrzB without p24 fell to 5.270.9%; p24 without GrzB was
reduced to 8.471.2%; and GrzBþ/p24þ was also reduced to
1.270.3% (po0.05 for each compared to respective UT cells,
n420). In saquinavir treated cells: GrzBþ/p24 was 8.972.3%;
GrzB/p24þ was 4.771.1% (po0.05 compared to UT cells); and
GrzBþ/p24þ was 0.570.2% (po0.05 compared to UT cells, n¼7).
These data show that GrzB/caspase-speciﬁc inhibitors (IETD-FMK)
also reduce intracellular HIV expression, and HIV-speciﬁc protease
inhibitors (saquinavir) reduce intracellular GrzB, indicating a
possible interdependent relationship between GrzB and HIV
production in memory CD4 T cells.
We also examined the viability of each GrzB/p24 population
(gated on CXCR4/CCR5 populations) to determine if GrzBþ cells
were more prone to apoptosis. Viabilities of the GrzBþ cells were
not signiﬁcantly different from GrzB cells, indicating that GrzB
is not causing death of memory CD4 T cells (data not shown).
The sum of these data show that both GrzB and HIV production
occurs most in CCR5þ memory CD4 T cells, but infected cells have
restricted ability to accommodate both GrzB and HIV at the single
cell level. Additionally, there may be some interdependence of
GrzB and HIV production in memory CD4 T cells that may involve
enhanced spread of infection to new cells.
Disruption of epithelial integrity by memory CD4 T cells, and
upregulation of GrzB by microbial ligands
HIV infection is associated with gastrointestinal pathologies,
such as memory CD4 T cell depletion, disruption of the epithelial
monolayer and translocation of microbial products, and chronic
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immune activation (Brenchley and Douek, 2012; Epple et al.,
2009). We found that CCR5 is associated with GrzB production
in memory CD4 T cells (puriﬁed from peripheral blood), but
memory CD4 T cells within GALT express higher levels of CCR5
compared to peripheral blood memory CD4 T cells, suggesting that
GrzB from CCR5þ memory CD4 T cells may have a role in
intestinal pathologies (Gordon et al., 2010; Veazey et al., 2000).
To ﬁrst determine the direct effect of GrzB on intestinal monolayer
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integrity, Caco-2 monolayers were treated apically with pure
GrzB protein for 24 h. Monolayer integrity was assessed by
measuring transepithelial resistances (TEER), and transcellular ﬂux
of ﬂuorescein-labeled sulfonic acid (Fluorescein-SA) markers at
experimental end-point. GrzB protein (o100 nM) inconsistently
and transiently caused TEER reductions, although higher amounts
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of GrzB (700 nM) increased transcellular permeability to
Fluorescein-SA after 24 h treatment (Fig. 5A, n¼2). To determine
the inﬂuence of memory CD4 T cells and GrzB on intestinal
epithelial integrity, uninfected or HIV-infected memory CD4 T
cells were cocultured basolaterally with Caco-2 cells for 4–5 days.
Disruption of Caco-2 TEER by IL2-stimulated memory CD4 T cells
was observed after 3–4 days of coculture and is presented as TEER
percent change from T0 (Fig. 5B). IL2 alone did not affect Caco-2
TEER, and Caco-2 in IL2 medium alone maintained stable resis-
tances during culture in which the day 4 TEER percent change
from T0 was approximately þ12% (n¼4). Additionally, uninfected
memory CD4 T cells without IL2 did not signiﬁcantly affect Caco-2
TEER (approximately 15%, p40.05 compared to Caco-
2þmedium alone). However, IL2-stimulated uninfected and HIV-
infected (R5-tropic) memory CD4 T cells decreased Caco-2 TEER.
IL2-stimulated uninfected memory CD4 T cells decreased Caco-2
TEER by 73%, and HIV-infected cells decreased TEER by 58%
(po0.05 compared to either Caco-2þmedium alone or Caco-
2þuninfected memory CD4 T cells without IL2). Culture of Caco-
2 alone with GrzB inhibitor IETD-FMK dramatically enhanced
TEER, possibly due to oxidative stress, which made interpretation
of Caco-2þmemory CD4 T cell coculture data with IETD-FMK
unclear. Attempts to knock down GrzB in memory CD4 T cells by
nucleofection (Amaxa) prior to coculture were unsuccessful due to
high toxicity of transfection. Activated memory CD4 T cells also
produce inﬂammatory cytokines such as TNFα and IFNγ, and these
cytokines are reported to disrupt epithelial monolayer integrity
(Cao et al., 2013; Resta-Lenert and Barrett, 2006; Wang et al.,
2005). However, coculture of HIV-infected memory CD4 T cells
with Caco-2 cells and blocking abs against TNFα and IFNγ did not
consistently mitigate TEER decreases. Additionally, HIV proteins
such as gp120 and Nef can impair epithelial integrity (Nazli et al.,
2010; Quaranta et al., 2011), but we observed no differences in
monolayer disruption between uninfected and HIV-infected cells,
indicating that the effect was caused by factors from activated
memory CD4 T cells.
These TEER changes were also corroborated by end-point
transcellular permeability of Fluorescein-SA markers (Fig. 5C). At
the conclusion of experiments, 1 mg/ml Fluorescein-SA was added
apically to Caco-2 cells in inserts for 3 h, and Fluorescein-SA
concentration in lower wells was measured. Fluorescein-SA per-
meability of Caco-2 monolayers in IL2 medium alone was 29 μg/
ml, and 48 μg/ml with unstimulated (no IL2) uninfected mem-
ory CD4 T cells. Fluorescein-SA permeability of Caco-2 cells with
uninfected memory CD4 T cells in IL2 medium was 170 μg/ml,
and 120 μg/ml with HIV-infected memory CD4 T cells (po0.05
compared to Caco-2þmedium alone and Caco-2þuninfected
memory CD4 T cells without IL2, n¼4). IETD-FMK alone reduced
Fluorescein-SA permeability. Blocking abs against TNFα and IFNγ
did not affect Fluorescein-SA permeability. Lastly, memory CD4 T
cell activation (410% CD69), as well as HIV (410,000 pg/ml) and
GrzB production (42000 pg/ml), by memory CD4 T cells was
mostly unaffected after 4–5 days coculture with Caco-2 cells (data
not shown). These data show that stimulated uninfected and HIV-
infected memory CD4 T cells can mediate the breakdown of
epithelial monolayers, which may involve GrzB.
During HIV infection, breakdown of the intestinal epithelial
monolayer occurs that results in translocation of microbial pro-
ducts, and is associated with chronic immune activation. TLR
ligands also promote activation of CD4 T cells and increase HIV
replication (Brichacek et al., 2010; Funderburg et al., 2008). To
determine if microbial products increase GrzB production, we
treated memory CD4 T cells with TLR ligands such as LPS (TLR4
agonist), Poly(I:C) (TLR3 agonist), Poly(U) (TLR8 agonist), peptido-
glycan (PGN) (TLR2 agonist), and Pam3CSK4 (TLR1/2 agonist). TLR
ligands alone did not affect T cell activation or GrzB production,
but PGN and Poly(U) enhanced CD25 expression and GrzB secre-
tion in conjunction with CD3/TCR activation after 2 days culture
(Fig. 5D and E). CD25 expression by CD3-activated memory CD4 T
cells was 23%, and increased to 36% with CD3þPoly(U) and to
31% with CD3þPGN stimulation (po0.05 compared to CD3
alone, n¼5). Extracellular GrzB by CD3-activated memory CD4 T
cells was 22,000 pg/ml, and increased to 51,000 pg/ml with
CD3þPoly(U) and 37,000 pg/ml with CD3þPGN stimulation
(po0.05 compared to CD3 alone). PGN and FSL-1 (synthetic
TLR2/6 agonist) also modestly increased HIV production by
10–20% compared to CD3/TCR alone (data not shown). Thus,
products of microbial translocation that stimulates TLR 2 or 8 on
memory CD4 T cells may contribute to their activation and
increased GrzB production.
Comparison of GrzB and CCR5 expression by CD4 T cells between
pathogenic and non-pathogenic SIV host monkeys
By contrast to natural/non-pathogenic SIV hosts (such as
African green monkeys and sooty mangabeys) that usually does
not develop simian AIDS and chronic immune activation, non-
natural/pathogenic SIV hosts (rhesus macaques and pigtail maca-
ques) experience these complications similarly to humans infected
with HIV. To determine if pathogenic SIV hosts express more GrzB
compared to non-pathogenic hosts, we examined peripheral blood
CD4 and CD8 T cells of RM and AGM. We examined blood samples
from 7 RM (all SIV) and 7 AGM (2 SIV and 5 SIVþ). PBMC were
isolated from blood, followed by positive selection for CD4 T cells
(80–90% CD3þCD4þ purity). CD4 T cells were then activated by
CD3/CD28 costimulation for 24 h, and stained for GrzB. Activation
increased CD4 T cell CD69 and extracellular GrzB similarly for RM
and AGM (Fig. 6A and B). Interestingly, one difference between RM
and AGM CD4 T cells was higher constitutive intracellular GrzB
expression by RM CD4 T cells (Fig. 6C–E). Fig. 6C shows represen-
tative GrzB dotplots gated on CD4 T cells of uninfected RM and
AGM, and Fig. 6D shows that CD4 T cells of most RM expressed
GrzB, whereas most AGM CD4 T cells expressed little to no GrzB.
When comparing RM to combined SIV and SIVþ AGM, resting
(UT) CD4 T cells of RM expressed signiﬁcantly more GrzB com-
pared to AGM (13.074.5% vs. 3.872.6%, po0.05). By contrast to
CD4 T cells, expression of GrzB by CD8 T cells was mostly similar
between RM and AGM, which was also higher than GrzB expres-
sion by CD4 T cells as expected (Fig. 6F). Lastly, memory
CD4þCD95þ cells of RM expressed modestly more CCR5
(7.571.7%) compared to AGM (2.371.0%, p¼0.057, n¼3), consis-
tent with previous reports (Pandrea et al., 2007), and CCR5
expression was reduced by activation (Fig. 6G). These differences
in GrzB and CCR5 expression by RM and AGM peripheral blood T
cells were modest, but these differences could be more pro-
nounced in GALT tissues where T cell activation and CCR5 expres-
sion is higher (Paiardini et al., 2011; Veazey et al., 2000; Wang
et al., 2011).
Discussion
HIV infection is characterized by memory CD4 T cell dysfunc-
tion and death, chronic immune activation, and tissue pathologies
such as enteropathy. HIV replication occurs mostly in activated
memory CD4 T cells, and is induced by CD3/TCR activation,
cytokines such as IL2, IL7, or IL15, and other agents such as TLR
ligands. In this report, we found that HIV production by stimulated
memory CD4 T cells is also accompanied with GrzB release, mostly
from CCR5þ memory CD4 T cells. Previous reports have shown
that HIV production by CD4 T cells is associated with release of
CD4 autocrine cytokines and chemokines, such as RANTES that
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affect HIV replication (Kinter et al., 1996). Concomitant release of
GrzB and HIV by memory CD4 T cells may be an important
element of HIV pathogenesis because granzymes are mediators
of cell death and tissue breakdown, and CCR5þ memory CD4 T
cells are highly activated and infected with HIV, especially in
lymphoid and intestinal tissues. Although CCR5 is best-known as a
coreceptor for HIV attachment and entry into CD4 T cells, CCR5
expression levels are positively associated with intestinal tissue
pathologies, increased immune activation, and disease progression
(Pandrea et al., 2007; Portales et al., 2012; Taaffe et al., 2012; Yang
et al., 2012). Additionally, the initial phases of primary HIV
infection are characterized by a predominance of HIV R5-tropic
strains, increased memory CD4 T cell activation, and substantial
amounts of viral production. The association of CCR5þ with both
HIV and GrzB production by memory CD4 T cells may inﬂuence
disease progression and AIDS.
Memory and effector CD4 T cells stimulated with CD3/CD28
costimulation, as well as by cytokines including IL2, IL7, IL15, IL6,
IL8, and TNFα, produced high amounts of GrzB and HIV (Figs. 1
and 3). GrzB and HIV are induced through similar signaling
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pathways in CD4 T cells, such as NFκB or JNK activation (Huang et
al., 2006; Medina et al., 2012; Wachstein et al., 2012). However,
concomitant production of HIV with host secreted factors (i.e. p24
with granzymes or cytokines) is mostly unexplored in memory
CD4 T cells. An interdependent effect between HIV and GrzB
secretion was not consistently observed with memory CD4 T cells,
although HIV infection increased GrzB production in Th1, Th17,
and differentiated naïve CD4 T cells (Fig. 3). Direct treatment of
CD4 T cells with recombinant GrzB or GrzA does not affect HIV
replication (Mackewicz et al., 2000). However, HIV replication in
conjunction with excessive release of GrzB is likely detrimental to
local tissues and bystander cells. GrzB functions extracellularly as a
protease and mediates ECM remodeling by cleaving proteins such
as ﬁbronectin and laminins, promoting inﬂammation and impair-
ing wound healing (Boivin et al., 2012; Buzza et al., 2005; Hiebert
and Granville, 2012). Extracellular GrzB in serum and tissues is
associated with inﬂammation and disease severity, and plasma
GrzB is increased in HIV-infected persons (Boivin et al., 2009).
In the context of the main HIV coreceptors, CCR5 and CXCR4, a
distinct pattern of intracellular GrzB expression was observed in
resting and activated memory CD4 T cells. GrzB expression was
highest in CCR5þ (CXCR4/CCR5þ and CXCR4þ/CCR5þ) mem-
ory CD4 T cells (Fig. 2A–C), although GrzB was also induced in
CCR5 (CXCR4/CCR5 and CXCR4þ/CCR5) memory CD4 T
cells by T cell activation. Whether GrzBþ or GrzB CCR5/CXCR4
cells represent independent memory CD4 subsets with unique
functions is unclear. These are not naïve CD4 T cells since memory
CD4 T cells were puriﬁed from PBMC for experiments (495%
CD4þCD45ROþCD45RA purity). Additionally, these CCR5þ
GrzBþ memory CD4 T cells do not clearly ﬁt within reported
CD4 CTL phenotypes (i.e. CD57þ , CD27-, CD28-). GrzB/perforin
expression and CTL functions are acquired by naïve CD4 T cells
following activation and differentiation into memory CD4 T cells,
which have increased CD57, and decreased CD27 and CD28
expression (Appay et al., 2002; Brown, 2010; Casazza et al.,
2006; Zaunders et al., 2004). Although CCR5þ memory CD4 T
cells in the present study expressed more CD57, and less CD27 and
CD28 compared to CCR5 cells, CD57 expression by CCR5þ cells
was modest (15%), and CD28 expression remained high (70%)
(Fig. 2D–F). Within the spectrum of memory CD4 T cell differ-
entiation, CCR5/GrzB cells are likely at earlier stages of
differentiation (i.e. CCR7þ , CD27þ , CD28þ), and CCR5þ/GrzBþ
cells are at later stages of differentiation (CD57þ , CCR7 , CD27 ,
CD28). Lastly, constitutive CCR5 expression by memory CD4 T
cells puriﬁed from peripheral blood in this study was 40%, but
CCR5 expression by memory CD4 T cells is higher in mucosal and
intestinal tissues (460–70%) (Douek et al., 2003; Kunkel et al.,
2002; Veazey et al., 2003). Tissue-resident memory CD4þ
CD45ROþ T cells that are CCR5þ/GrzBþ/CXCR47 may represent
pathogenic or inﬂammatory subsets of memory/effector CD4 T
cells, whereas CXCR4þ/CCR5/GrzB memory CD4 T cells may
be benign or perhaps regulatory or anti-inﬂammatory subsets.
During HIV infection, we further observed another interesting
pattern of intracellular GrzB and p24 protein expression by CCR5þ
memory CD4 T cells in IL2 medium. HIV p24 and GrzB protein
were the highest in CCR5þ memory CD4 T cells, but memory CD4
T cells had limited capacity for producing both simultaneously
(Fig. 4A and B). This supports the idea that GrzB and HIV secretion
require similar pathways in CCR5þ memory CD4 T cells, consis-
tent with a previous report showing HIV Env colocalization with
secretory lysosomal proteins (CD63, CTLA-4, cathepsin D, and FasL)
at virological synapses in primary CD4 T cells, although Env
colocalization with GrzB or perforin was not examined (Jolly et
al., 2011). Also consistent with the idea that HIV secretion requires
GrzB-related secretory pathways, we observed that treating mem-
ory CD4 T cells with the compound Z-IETD-FMK (a synthetic cell-
permeable inhibitor of GrzB and caspase 8/10 activity) reduced
intracellular GrzB and p24, whereas treatment with the HIV
posttranslational protease inhibitor saquinavir reduced p24 but
not GrzB (Fig. 4C). Whether functional activity of GrzB or caspases
regulate HIV infection is unclear, although direct treatment of
HIV-infected CD4 T cells with recombinant GrzA or GrzB does not
affect HIV replication (Mackewicz et al., 2000). At a single cell
level, it is unclear if HIV virion assembly and secretion actually
interferes with GrzB secretion by memory CD4 T cells because
intracellular and extracellular GrzB production was similar
between uninfected and HIV-infected cells. Secretion of GrzB and
HIV virions is regulated by secretory mechanisms such as ESCRT I,
II, and III pathways (endolysosomal and endosomal sorting com-
plex required for transport). Although there is likely overlap or
competition for host secretory components, it is unclear how
much HIV and GrzB secretory pathways are intertwined. Addi-
tionally, temporal and kinetic aspects of HIV and GrzB secretion
are likely important (i.e. secretory pathways of activated CCR5þ
memory CD4 T cells may initially be devoted mostly to granzyme
or cytokine secretion, then gradually overcome by HIV virion
secretion). These intracellular p24 vs. GrzB patterns may also
differ compared to other secreted mediators that utilize different
secretory mechanisms in CD4 T cells (i.e. p24 vs. cytokines) (Huse
et al., 2006). These data support the well-known fact that HIV
hijacks secretory pathways in CD4 T cells, but may further clarify
the concept by showing that p24 secretion is limited in CCR5þ
memory CD4 T cells in which the secretory pathway is actively
involved in secretion of host mediators, such as GrzB or cytokines,
prior to posttranscriptional steps of HIV replication. Alternatively,
Fig. 4A and B may also suggest that HIV preferentially infects and
replicates in CCR5þ memory CD4 T cells that do not express GrzB,
as GrzB expression by IL2-stimulated CCR5þ memory CD4 T cells
was usually o20%.
We observed that IL2-stimulated uninfected and HIV-infected
memory CD4 T cells impaired Caco-2 monolayer integrity by
decreasing TEER and increasing transcellular permeability. How-
ever, no differences in monolayer disruption were observed
between uninfected and HIV-infected memory CD4 T cells, which
are not surprising (Fig. 5B and C). A clear role for GrzB secreted by
memory CD4 T cells was not established, as a GrzB pharmacolo-
gical inhibitor (IETD-FMK) did not mitigate these monolayer
effects, although transcellular permeability of monolayers was
increased by direct treatment with pure GrzB (Fig. 5A). It is
possible that extracellular GrzB activity may be transient or have
a short half-life. Further confounding these results was the
increased TEER caused by the IETD-FMK compound. Experiments
with more speciﬁc inhibitors of GrzB are needed, but such
inhibitors currently do not exist. A large proportion of lamina
propria CD4 T cells are activated memory CD4 T cells that express
CD45RO and CD69, and activated T cells are reported to disrupt
epithelial barriers. For example, CD3-activated intraepithelial
lymphocytes (IEL's) induce death of intestinal epithelial cells and
villus breakdown in perforin-knockout mice, although the speciﬁc
IEL subsets (CD4 or CD8) involved were not determined (Ogata
et al., 2013). Activated memory CD4 T cells also express IFNγ and
TNFα, and recombinant IFNγ or TNFα impair Caco-2 or T84
epithelial monolayers (Bruewer et al., 2003; Cui et al., 2010).
However, we did not observe a clear role for memory CD4 T cell
IFNγ or TNFα in monolayer disruption by using blocking abs. It is
likely that a variety of factors secreted by memory CD4 T cells,
either alone or synergistically, mediate the breakdown of intest-
inal epithelial integrity.
Breach of the intestinal epithelium results in microbial trans-
location, which is associated with systemic CD4 T cell activation.
We observed that TLR ligands alone generally do not affect
memory CD4 T cell activation, consistent with other reports
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(Funderburg et al., 2008), but did ﬁnd that peptidoglycan or
poly(U) (TLR 2 and 8 agonists) enhanced GrzB production in
concert with CD3/TCR activation (Fig. 4D and E). In addition to
promoting chronic immune activation of memory CD4 T cells
during HIV infection, persistent exposure to TLR ligands likely
upregulates GrzB release and contributes to immune exhaustion.
The clear conclusion from these in vitro experiments is that
stimulated, GrzB-producing, uninfected and HIV-infected memory
CD4 T cells can induce breakdown of an intestinal monolayer, and
microbial products may further promote CD4 T cell activation and
production of HIV and GrzB.
We hypothesized that GrzB expression by CD4 T cells of
pathogenic, non-natural SIV host monkeys (RM) may be higher
compared to non-pathogenic, natural SIV hosts (AGM), which may
be a relevant difference for SIV pathogenesis (Fig. 6). By contrast to
AGM's, RM's experience human AIDS-like diseases during SIV
infection such as CD4 T cell depletion, enteropathies, and chronic
immune activation, despite high viral loads in both species and
similar degrees of antiviral responses (Brenchley and Paiardini,
2011; Paiardini et al., 2009). We previously reported that
pathogenic SIV hosts (RM and pigtail macaques) contain more
GrzB-expressing CD4 T cells in intestinal tissues compared to non-
pathogenic SIV hosts (AGM and sooty mangabeys) (Hutchison et
al., 2011). In the present study of peripheral blood T cells, we
further observed differences in GrzB and CCR5 expression, in
which RM CD4 T cells expressed more intracellular GrzB than
AGM (Fig. 6C–E). Although RM and AGM secreted comparable
amounts of GrzB after strong CD3/CD28 activation in vitro, extra-
cellular secretion may differ with more modest stimulants such as
microbial ligands or cytokines in vivo. We also observed that AGM
memory CD4þCD95þ T cells express little CCR5 (2%), which is
consistent with other reports showing minimal CCR5 expression
by peripheral blood CD4 T cells of natural SIV hosts (Pandrea et al.,
2007), whereas RM CD4þCD95þ T cells expressed higher levels of
CCR5 (Fig. 6G). However, CCR5 expression by memory CD4 T cells
is much higher in intestinal tissue compared to peripheral blood in
pathogenic SIV hosts and humans. Expression of GrzB and CCR5 by
memory CD4 T cells may be an important difference between SIV
hosts because pathogenic SIV hosts experience higher immune
activation, harbor more CD4 T cells in intestinal tissue, and express
more CCR5 by CD4 T cells compared to non-pathogenic SIV hosts.
However, it is also possible that decreased expression of CCR5
during primary HIV infection of normal individuals is also asso-
ciated with decreased GrzB expression by memory CD4 T cells,
suggesting a lesser role for CCR5þGrzBþ memory CD4 T cells
during HIV-associated pathologies.
During HIV infection, CD4 T cells release mediators such as
cytokines and chemokines that inﬂuence HIV pathogenesis, but
the release of GrzB from CCR5þ memory CD4þ T cells may be an
important aspect of infection as well, particularly for bystander
cells. In addition to CD8 T cells and NK cells, higher levels of
extracellular GrzB during infection and disease can come from CD4
T cells, regardless of their infection status.
Materials and methods
CD4 T cell puriﬁcations
Human PBMC of healthy donors (Gulf Coast Regional Blood
Center, Houston, TX, USA) were isolated by Ficoll-Paque PLUS (GE
Healthcare, Piscataway, NJ, USA). Memory CD4þCD45ROþ , naïve
CD4þCD45RAþ , Th1, and Th17 cells were then puriﬁed from
PBMC by magnetic bead-based negative selection kits (Stemcell
Technologies, Vancouver, BC, Canada), and purities were assessed
by ﬂow cytometry. Memory CD4 T cell purity was at least 90–95%
CD4þCD45ROþCD45RA , and naïve CD4 T cell purity was at
least 96% CD4þCD45RAþCD45RO . Th1 purity (after depletion
of CD8, CD14, CD16, CD19, CD56, CCR4, and glycophorin A cells
from PBMC) was assessed by activating Th1 cells with PMA/IO for
4 h in the presence of GolgiPlug (BD Biosciences, San Jose, CA,
USA), followed by intracellular staining for IL2, IFNγ, or IL4, in
which activated Th1's expressed IL2 (30%) and IFNγ (20%), and
no IL4. Th17 cells were puriﬁed from PBMC by negative selection
for CD4þCD45ROþ T cells, followed by positive selection for
CCR6þ (Stemcell Technologies), and purity was assessed by
staining for CCR6 (490%) and CXCR3 (o10%).
HIV infections
Memory CD4, Th1, Th17, or activated naïve CD4 T cells were
infected with primary or lab-adapted HIV-1 strains. Virus stocks
were produced by the Baylor/UT-Houston Center for AIDS
Research (CFAR, Houston, TX, USA), an NIH-funded program.
R5-tropic strains used include NSN-SX, JR-CSF, and SF162. X4-
tropic strains include 93BR019, ELI, and NL4.3. R54 dual-tropic
strains were 89.6. For infection of resting memory CD4, Th1, and
Th17 cells, cells were infected by culturing overnight in complete
RPMI mediumþ20 ng/ml rIL2 (Biolegend, San Diego, CA, USA) with
HIV stocks at MOI's of 0.01–0.1, and uninfected cells were cultured
in IL2 medium alone. After overnight infection, cells were washed
2 in medium and used for experiments. For infection of pre-
activated memory CD4 T cells, cells were ﬁrst activated with 1 μg/
ml coated CD3 (clone UCHT1)þ1 μg/ml soluble CD28 (clone
CD28.2) mabs (BD Biosciences) for 2 days in IL2 medium. Cells
were then washed and cultured in medium alone or with HIV
stocks at 0.01–0.1 MOI overnight in IL2 medium. Cells were then
washed and used for experiments. For infection of activated naïve
CD4 T cells, puriﬁed naïve CD4 T cells were ﬁrst activated with CD3/
CD28 costimulationþ IL2, or cultured with IL2 alone for 3 days. Cells
were then washed and infected with HIV overnight (R5-tropic
strains at 0.1 MOI) in IL2 medium. Uninfected and infected cells
were then washed and cultured in IL2 medium for experiments.
Cell culture experiments, pharmacological inhibitors, and TLR ligands
Most experiments involved culture of uninfected or HIV-
infected memory CD4 T cells in IL2 (20 ng/ml) medium for up to
1 week, followed by data collection. Cells were cultured in 48-well
plates (5105 cells in 1 ml medium) with appropriate reagents.
The HIV antiviral inhibitor, Saquinavir, was acquired from NIHAIDS
Reagent Program and used at 1-10 μg/ml. The GrzB/caspase
inhibitor, Z-IETD-FMK (Enzo Life Sciences, Farmingdale, NY, USA),
was used at 10 μM. Experiments involving TLR stimulation of
memory CD4 T cells utilized synthetic TLR ligands LPS (Sigma, St.
Louis, MO, USA), Pam3CSK4 (EMD Millipore, Billerica, MA, USA),
peptidoglycan, Poly(I:C), and Poly(U) (InvivoGen, San Diego, CA,
USA), and were used at 2-25 μg/ml 7CD3 activation (clone UCHT1
coated at 0.1 μg/ml).
Flow cytometry
Flow cytometry studies of memory and naïve CD4, Th1, and
Th17 cells involved surface staining for CD4 (PerCPCy5.5), CD45RO
(Paciﬁc blue), CD45RA (APC), CD62L (PE), CCR5 (FITC, PE, AF647,
Paciﬁc blue), CXCR4 (PerCPCy5.5, APC), CD69 (PECy7, APC, AF647,
APCCy7), CD57 (FITC), CD27 (PerCPCy5.5), or CD28 (PE) (all from
BD Biosciences or Biolegend, San Diego, CA, USA). Intracellular
mabs include GrzB (clone GB11- or GB12-PE, FITC, APC, AF700
from BD Biosciences, Biolegend, or Life Technologies, Grand Island,
NY, USA), p24 (clone KC57-PE from Beckman-Coulter, Miami, FL,
USA), and IFNγ (PE) or IL17A (Paciﬁc blue) from Biolegend. Fixable
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Live/Dead viability dyes (Life Technologies) were also utilized.
Cells were stained by ﬁrst washing with PBS/2% FBS (wash buffer),
then incubating 30 min with viability dye. Cells were washed, then
incubated 30 min with surface mabs. Cells were then washed, and
ﬁxed 30 min with Cytoﬁx/Cytoperm solution (BD Biosciences).
Cells were then washed with Cytoperm buffer, and incubated
30 min with intracellular mabs. Cells were then washed with
Cytoperm buffer and stored at 4 1C until data acquisition.
Unstained, isotype, or FMO controls were used to distinguish
between negative and positive signals. Data was acquired with a
Gallios Flow Cytometer and analyzed with Kaluza software (Beck-
man-Coulter).
For Th1 and Th17 intracellular cytokine assays (ICS), Th1 and
Th17 cells were cultured for 6 days, then stimulated with PMA/
IOþGolgiPlug (Leukocyte Activation Cocktail, BD Biosciences) for
the ﬁnal 5 h. Cells were then stained for CXCR4, CCR5, CCR6, IFNγ,
IL17A, p24, or GrzB via Cytoﬁx/Cytoperm solutions.
ELISA
Extracellular GrzB and HIV p24 protein were measured in cell-
free supernatants by ELISA kits. GrzB sandwich ELISA kits were
from Mabtech (Mariemont, OH, USA). High-binding 96-well plates
(Nunc) were ﬁrst coated overnight at 4 1C with 2 μg/ml GrzB mab
(clone GB10) in PBS. After coating, plates were washed with PBS.
Plates were then blocked with PBS/0.05% Tween-20/0.1% BSA.
Plates were then washed and samples added for 2 h at room
temp. After sample incubation, plates were washed and GrzB-
biotin (clone GB11) added for 1 h. Plates were then washed and
streptavidin-HRP added for 1 h. Plates were then washed and TMB
substrate added for 15 min, followed by addition of TMB stop
solution. 450 nm OD's were then recorded with an absorbance
plate reader (Tecan, San Jose, CA, USA). Sample GrzB concentra-
tions were determined from standard curve with a detection limit
of 4 pg/ml.
HIV p24 ELISA kits were from Advanced Bioscience Laboratories
(Rockville, MD, USA). Samples were incubated with disruption
buffer in 96-well plates for 1 h at 37 1C. Plates were then washed
and conjugate solution added for 1 h. Plates were washed and TMB
substrate added for 30 min, followed by the addition of TMB stop
solution. 450 nm OD's were recorded with an absorbance plate
reader. Sample p24 concentrations were determined from stan-
dard curve with a detection limit of 3 pg/ml.
Cocultures of Caco-2 epithelial cells with memory CD4 T cells
Caco-2 human colon epithelial cell lines (ATCC, Manassas, VA,
USA) were used to determine the effects of memory CD4 T cells on
intestinal epithelial monolayer integrity. Prior to coculture with
memory CD4 T cells, Caco-2 cells were ﬁrst grown to conﬂuency
on collagen-coated transwell inserts (0.4 μm pore size, Corning
3495) in 24-well plates and DMEM medium. Monolayer integrity
was monitored by measuring transepithelial electrical resistances
(TEER) with an EVOM2 epithelial voltohmmeter (World Precision
Instruments, Sarasota, FL, USA). Baseline TEER's were 800–
1,000 Ω/cm2 before starting experiments. Following establishment
of baseline resistances, inserts were then transferred to new
24-well plates containing pre-seeded (immediately prior to
Caco-2 transfer) memory CD4 T cells in lower wells (5105 cells
in 1 ml medium basolaterally). Caco-2 cells were cocultured with
memory CD4 T cells and appropriate reagents for up to 5 days, and
TEER's were measured every 24 h. For assessment of Caco-2
monolayer transcellular permeability at the conclusion of cocul-
ture experiments with memory CD4 T cells, inserts were trans-
ferred to new 24-well plates containing fresh DMEM medium.
1 mg/ml ﬂuorescein-labeled sulfonic acid (FL-SA, Life
Technologies) was then added to inserts for 3 h, and samples
harvested from lower wells. Fluorescence intensities were mea-
sured with a ﬂuorescence plate reader (BioTek, Winooski, VT, USA)
and concentrations determined by standard curve.
For coculture experiments using blocking abs, anti-IFNγ
(Biolegend), anti-TNFα (R&D Systems, Minneapolis, MN, USA), or
isotype controls were used at 2–5 μg/ml. Caco-2 monolayers were
also directly treated with pure recombinant GrzB (ImmunoChem-
istry Technologies).
Studies of non-human primates
Studies of NHP peripheral blood cells involved rhesus maca-
ques (RM) and African green monkeys (AGM). NHPs were main-
tained at the New England Primate Research Center (Boston, MA,
USA). Whole blood of NHP's were drawn and shipped to UT-
Houston Medical School for experiments. PBMC were then isolated
via ﬁcoll, followed by positive selection of CD4 T cells using a
primate-speciﬁc CD4 mab (clone L200 from BD Biosciences), and
CD3þCD4þ purities were 80–90%. Cells were then cultured in
complete RPMI medium for experiments. Cells were unstimulated
or activated with 5 μg/ml coated CD3 (clone SP34)þ2 μg/ml
soluble CD28 (clone CD28.2) mabs (BD Biosciences) for 24 h. Cells
were then stained for CD3 (Paciﬁc blue), CD4 (PerCPCy5.5), CD8
(APCCy7), CCR5 (PE), CD95 (APC), CD69 (ECD), and GrzB (AF700)
(BD Biosciences) using Cytoﬁx/Cytoperm solutions. Extracellular
GrzB was measured by ELISA kit (Cell Sciences, Canton, MA, USA).
Statistics
The analyses were performed using SAS 9.3 or MS Excel. The
means by experimental conditions were compared by two sample
t-tests for independent samples and paired t-tests for paired
samples respectively. For the highly skewed variables, the loga-
rithm transformation was made for analysis. Pearson correlation
coefﬁcient was calculated to assess the correlation between two
continuous variables. A two-sided p-value o0.05 was considered
statistically signiﬁcant.
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